Clinical Trial Update: A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update on preemptive therapy for Hepatitis C in organ transplant recipients. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Mayo Clinic | Conditions: Hepatitis C, Kidney Transplant; Complications | Phase 4 | Status: ACTIVE_NOT_RECRUITING